How Sensor-Enhanced Patient Data Completes the Story of the Trial

Think about the last time a doctor asked How is your sleep pattern? Chances are you probably said “not great” or “fine, mostly.” In some cases, you can’t even remember and might have been tossing and turning. In clinical trials, those answers do matter. But a summary relies on memory, and at that hour, memory isn’t always reliable, especially at 3 a.m. This is the gap where Dr Helen Brooker, Director of Product and Clinical Data at Signant Health, spends her time. A neuropsychologist by training, she joined Digital Pulse host Trisha Pillay to explain why pairing questionnaires with wearable sensors may be the most practical upgrade clinical trials can make right now. For more information, visit signanthealth.com and Ametris.com. Takeaways Integration of sensors and wearables in clinical trials. Benefits of continuous passive data collection. Regulatory perspectives and approvals. Impact on trial design and data analysis. Case study: eczema trial with wrist sensors. Signet Health and Ametris partnership. Chapters 00:00 Introduction to sensors and wearables in clinical trials 00:54 Helen Brooker's background and passion for clinical research 03:42 The added value of sensors to clinical outcome assessments 04:06 How sensors provide invisible, objective data 07:40 Real-world example: eczema trial with wrist sensors 10:55 Why sensors are not yet routine in trials 13:52 Signant Health and Ametris partnership for innovation 16:49 Designing trials with continuous sensor data 19:01 Analysing sensor data in clinical trials 20:47 Patient recruitment and data accuracy 22:01 Regulatory perspectives and approvals 25:12 Integrating sensors with established assessments 28:23 Add sensors to existing ECOA studies 29:34 Closing thoughts and future outlook ‪@Pharmatica_io‬ ‪@signethealth‬ @TheActigraph #ClinicalTrials #DigitalHealth #eCOA #WearableTechnology #ClinicalResearch #PatientReportedOutcomes #Pharmatica #DigitalPulse #SignantHealth #SensorEnhancedTrials